Dexfenfluramine in psychotic patients.
Dexfenfluramine (DF) is contraindicated in severe psychiatric disorders and in depression. We used DF in 3 patients with chronic psychosis and severe overeating without changes in psychiatric pharmacotherapy. Two patients had paranoid schizophrenic psychosis with hallucinations, one patient mixed psychosis, beginning with lactation psychosis, and several attacks of hallucinations and depression later. Overeating was removed in all 3 patients without any negative effect on the psychotic state. All patients were able to maintain their body weight. Two patients with poorly controlled diabetes improved markedly their metabolic status. Doses up to 75 mg per day of DF were necessary during binge eating episodes in one patient. We conclude that DF can be used with care under close psychiatric supervision in psychotic patients with severe overeating.
Svacina
S
S
3rd Medical Clinic, 1st Medical Faculty, Charles University, Prague, Czech Republic.
Sonka
J
J
Marek
J
J
D000328:Adult; D001067:Appetite Depressants / Q000627:therapeutic use*; D000075202:Contraindications; D020372:Dexfenfluramine / Q000627:therapeutic use*; D001068:Feeding and Eating Disorders / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000188:drug therapy; D011618:Psychotic Disorders / Q000150:complications*; D012559:Schizophrenia / Q000150:complications
D001067:Appetite Depressants; D020372:Dexfenfluramine